Oz acknowledged obesity isn't "a deficiency of GLP drugs" but called reducing costs "a belt-and-suspenders approach." ...

Donald Trump hailed his deal to slash the price of blockbuster weight loss drugs as a game changer. But major gaps in the ...

People taking GLP-1 meds could see costs drop in 2026, thanks to a new federal deal with Eli Lilly and Novo Nordisk, the ...

A new deal between the White House and pharmaceutical companies like Novo Nordisk and Eli Lilly is shaking things up.

The deal announced on Thursday, covering Novo's Wegovy and Lilly's Zepbound, will reduce monthly prices for U.S. government ...

The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned with those paid in other countries, known as ...

Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more ...

According to recent Gallup data, obesity rates in the United States fell back down to 37 percent this year, from hitting a ...

The White House today announced landmark drug pricing agreements with Eli Lilly and Company and Novo Nordisk to lower the ...

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...

A pioneer in diabetes care, Novo Nordisk has been in the business for over 85 years. It claims 34% of the $80 billion-plus diabetes treatment market and roughly half of the more than $15 billion ...